Sign in to view content

Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial

Peter A. Campochiaro, MD

Video
Published 2021

Related

Foveal Capillary Perfusion Density Decreases in Diabetics with DME Treated on a Fixed Regimen of Intravitreal Aflibercept Injections Over 24 Months
Brittney Statler, MD
Updates from the Field
2020
Episode 147: CEP290 mRNA intravitreal therapy for LCA
Jayanth Sridhar, MD
Member Podcasts
2018
Trends in the treatment of proliferative diabetic retinopathy before and after the Diabetic Retinopathy Clinical Research Network Protocol S study
John W Hinkle, MD
Updates from the Field
2020

Category: Pharmacology

See more